News from decision resources A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( EuronextParis:BND)

12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Payers Exert Cost Controls on High-Cost Biologics to Treat Autoimmune Conditions

Decision Resources Group finds that surveyed managed care organizations (MCOs) anticipate that their costs of covering biologic treatments of...

10:10 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023

 Decision Resources Group finds that the Japanese electrophysiology (EP) mapping and ablation device market will expand through 2023 as...

10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market

 Decision Resources Group finds that the vascular access device market in Brazil, Russia, India and China (BRIC) was valued at approximately...

Aug 19, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Nearly Half of Surveyed Specialists Expect to Prescribe Gilead's Sofosbuvir/Ledipasvir Regimen Near-Term for Hepatitis C Infections

 Decision Resources Group finds that, for the treatment of hepatitis C virus (HCV) infections, 40 percent of surveyed HCV treating specialists...

Aug 18, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Decision Resources Group Triples Coverage On U.S. Longitudinal Patient Claims Data Analytics

 Decision Resources has expanded its disease-level coverage of the Treatment Algorithms Insight Series, which examines U.S. physicians'...

Aug 18, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Xeljanz's Label Extension to Include Reduction of Radiographic Progression of Structural Joint Damage in RA Has Positively Impacted U.S. Rheumatologists' Perceptions of This Agent

 Decision Resources Group finds that the FDA approval of Pfizer's supplemental New Drug Application for Xeljanz in February 2014 to include the...

Aug 14, 2014, 12:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

U.S. and European Soft Tissue Repair Device Markets Will Expand Modestly In Line With Large Hernia Repair Device Market

 Decision Resources Group finds that the soft tissue repair device markets in the United States and Europe will expand slightly through 2022....

Aug 14, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Physician-Reported Patient Share for Regeneron's Eylea Has Now Stabilized Following Significant Increases after Its U.S. Launch for Wet Age-Related Macular Degeneration

 Decision Resources Group finds that physician-reported patient shares for Regeneron's Eylea, as well as the other major anti-vascular...

Aug 13, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Improving Outlook in the U.S. Market is Due to Specialty Product Opportunities and Broader Patient Access with Implementation of the Affordable Care Act and Expansion of Medicaid

Decision Resources Group finds that the outlook for the pharmaceutical market in the United States is becoming more favorable, as the size of the...

Aug 13, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Impact of Genericization in the Unipolar Depression Market Will be Tempered by the Continued Uptake of Novel Antidepressants and Antipsychotics

 Decision Resources Group finds that in the unipolar depression* market, the expanding use of two recently approved...

Aug 12, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Changes Wrought by Affordable Care Act Lead to Surge in Private Exchanges

 Decision Resources Group finds that interest in private exchanges has sharply increased as the Affordable Care Act has gotten officially...

Aug 11, 2014, 16:55 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Asia Pacific Transcatheter Embolization and Occlusion Device Market Will Be Driven By the Adoption of Flow-Diverting Devices and Radioembolization Spheres

 Decision Resources Group finds that the Asia Pacific market for transcatheter embolization and occlusion (TEO) devices—including...

Aug 11, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Imatinib And Sunitinib Will Continue To Dominate Patient Share In The Patient Populations That They Are Approved For Through 2023

 Decision Resources Group finds that the treatment landscape of gastrointestinal stromal tumors (GIST) will not change dramatically through...

Aug 07, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Launch of Five Immunomodulatory Therapies for Relapsing Forms of Multiple Sclerosis Will Contribute to 4 Percent Annual Growth of the Total Market from 2013 to 2023

 Decision Resources Group finds that the forecast launch of Biogen Idec's Plegridy, Roche/Genentech's ocrelizumab, Biogen Idec/AbbVie's...

Aug 07, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The U.S. Spinal Implant Market Will Grow Modestly to Reach $7.1 Billion by 2022

 Decision Resources Group finds that the United States spinal implant market will expand modestly through 2022 to reach a value of nearly $7.1...

Aug 06, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

High Need for a New Phosphate Binder Exists--Fewer Pills, Better Efficacy in Reducing Phosphorus and Improved Tolerability Rated as Higher Unmet Needs

Decision Resources Group finds that there is a high need for new phosphate binders to treat hyperphosphatemia among surveyed U.S. nephrologists...

Aug 06, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

At One Year Post-Launch, Over Two Thirds of Surveyed U.S. Medical Oncologists Have Prescribed Xofigo to Their Prostate Cancer Patients

Decision Resources Group finds that at one year post-launch in the United States, over two thirds of surveyed U.S. medical oncologists have...

Aug 06, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Driven By Product Innovations, the U.S. Drug Delivery Device Market Will Reach Over $4.5 Billion by 2022

 Decision Resources Group finds that the United States drug delivery device market will grow at a strong rate to reach a value of over $4.5...

Aug 05, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Canadian Peripheral Vascular Device Market Will Only Expand Slightly As Procedure Growth is Largely Offset by Declining Prices

 Decision Resources Group finds that the Canadian market for peripheral vascular (PV) devices will grow slightly through 2022 as procedural...

Aug 04, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Surveyed U.S. Rheumatologists' Experience Prescribing Celgene's Otezla at One Month Post Launch Is Less Than 30 Percent But Is Expected to More Than Double Within the Next Month

BURLINGTON, Mass., Aug. 4, 2014 Decision Resources Group finds that at one month post commercial availability, surveyed U.S. rheumatologists have...